Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells

World Journal of Gastroenterology

Volumn 19, Issue 24, 2013, Pages 3792-3801

  Zhang, Hai Jian ^a   Yao, Deng Fu ^a   Yao, Min ^a   Huang, Hua ^a   Wang, Li ^a   Yan, Mei Juan ^a   Yan, Xiao Di ^a   Gu, Xing ^a   Wu, Wei ^a   Lu, Shao Lin ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Annexin A2; Hepatocellular carcinoma; Invasion; Migration; Small hairpin RNA; Tumorigenic potential

Indexed keywords

COMPLEMENTARY DNA; LIPOCORTIN 2; SHORT HAIRPIN RNA;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR INVASION; TUMOR XENOGRAFT; ULTRAVIOLET SPECTROPHOTOMETRY; WESTERN BLOTTING; WOUND HEALING;

EID: 84879581073     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i24.3792     Document Type: Article

References (35)

1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255 [PMID: 22353262 DOI: 10.1016/ S0140-6736(11)61347-0]
2. Shen YC, Hsu C, Cheng CC, Hu FC, Cheng AL. A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression. Oncology 2012; 82: 275-289 [PMID: 22555181 DOI: 10.1159/000337293]
3. DuBray BJ, Chapman WC, Anderson CD. Hepatocellular carcinoma: a review of the surgical approaches to management. Mo Med 2011; 108: 195-198 [PMID: 21736080]
4. Lencioni R, Crocetti L. Local-regional treatment of hepa-tocellular carcinoma. Radiology 2012; 262: 43-58 [PMID: 22190656 DOI: 10.1148/radiol.11110144]
5. Vullierme MP, Paradis V, Chirica M, Castaing D, Belghiti J, Soubrane O, Barbare JC, Farges O. Hepatocellular carcinoma--what's new? J Visc Surg 2010; 147: e1-12 [PMID: 20595072 DOI: 10.1016/j.jviscsurg.2010.02.003]
6. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674 [PMID: 21376230 DOI: 10.1016/j.cell.2011.02.013]
7. Marquardt JU, Galle PR, Teufel A. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J Hepatol 2012; 56: 267-275 [PMID: 21782758 DOI: 10.1016/j.jhep.2011.07.007]
8. Sia D, Villanueva A. Signaling pathways in hepatocellular carcinoma. Oncology 2011; 81 Suppl 1: 18-23 [PMID: 22212931 DOI: 10.1159/000333254]
9. Teufel A, Marquardt JU, Galle PR, Wörns M. [Hepatocellular carcinoma: what's new?]. Dtsch Med Wochenschr 2012; 137: 210-213 [PMID: 22250042 DOI: 10.1055/s-0031-1292890]
10. Lokman NA, Ween MP, Oehler MK, Ricciardelli C. The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 2011; 4: 199-208 [PMID: 21909879 DOI: 10.1007/s12307-011-0064-9]
11. Madureira PA, Surette AP, Phipps KD, Taboski MA, Miller VA, Waisman DM. The role of the annexin A2 heterotet-ramer in vascular fibrinolysis. Blood 2011; 118: 4789-4797 [PMID: 21908427 DOI: 10.1182/blood-2011-06-334672]
12. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002; 82: 331-371 [PMID: 11917092]
13. Flood EC, Hajjar KA. The annexin A2 system and vascular homeostasis. Vascul Pharmacol 2011; 54: 59-67 [PMID: 21440088 DOI: 10.1016/j.vph.2011.03.003]
14. Mohammad HS, Kurokohchi K, Yoneyama H, Tokuda M, Morishita A, Jian G, Shi L, Murota M, Tani J, Kato K, Miyo-shi H, Deguchi A, Himoto T, Usuki H, Wakabayashi H, Izuishi K, Suzuki Y, Iwama H, Deguchi K, Uchida N, Sabet EA, Arafa UA, Hassan AT, El-Sayed AA, Masaki T. Annexin A2 expression and phosphorylation are up-regulated in he-patocellular carcinoma. Int J Oncol 2008; 33: 1157-1163 [PMID: 19020748]
15. Zheng L, Foley K, Huang L, Leubner A, Mo G, Olino K, Edil BH, Mizuma M, Sharma R, Le DT, Anders RA, Illei PB, Van Eyk JE, Maitra A, Laheru D, Jaffee EM. Tyrosine 23 phosphorylation-dependent cell-surface localization of an-nexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One 2011; 6: e19390 [PMID: 21572519 DOI: 10.1371/journal.pone.0019390]
16. Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K, Tachibana M. Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer 2009; 101: 287-294 [PMID: 19513064 DOI: 10.1038/sj.bjc.6605128]
17. Sharma M, Ownbey RT, Sharma MC. Breast cancer cell surface annexin II induces cell migration and neoangio-genesis via tPA dependent plasmin generation. Exp Mol Pathol 2010; 88: 278-286 [PMID: 20079732 DOI: 10.1016/ j.yexmp.2010.01.001]
18. Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li Y, Jiang JL, Zhang SH, Chen ZN. Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci 2010; 101: 387-395 [PMID: 20047591 DOI: 10.1111/j.1349-7006.2009.01420.x]
19. Zhang HJ, Li C, Zhang GY. ATPA induced GluR5-containing kainite receptor S-nitrosylation via activation of GluR5-Gq-PLC-IP(3)R pathway and signalling module GluR5·PSD-95·nNOS. Int J Biochem Cell Biol 2012; 44: 2261-2271 [PMID: 23000395]
20. Gao J, Zhu J, Li HY, Pan XY, Jiang R, Chen JX. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells. Int J Biochem Cell Biol 2011; 43: 1294-1304 [PMID: 21601006 DOI: 10.1016/j.biocel.2011.05.003]
21. Zhao P, Zhang W, Wang SJ, Yu XL, Tang J, Huang W, Li Y, Cui HY, Guo YS, Tavernier J, Zhang SH, Jiang JL, Chen ZN. HAb18G/CD147 promotes cell motility by regulating an-nexin II-activated RhoA and Rac1 signaling pathways in he-patocellular carcinoma cells. Hepatology 2011; 54: 2012-2024 [PMID: 21809360 DOI: 10.1002/hep.24592]
22. Ruan J, Liu F, Chen X, Zhao P, Su N, Xie G, Chen J, Zheng D, Luo R. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line. Int J Mol Med 2011; 28: 497-503 [PMID: 21617840]
23. Wang D, Xu MR, Wang T, Li T, Zhu JW. MTSS1 overexpression correlates with poor prognosis in colorectal cancer. J Gastrointest Surg 2011; 15: 1205-1212 [PMID: 21562916 DOI: 10.1007/s11605-011-1546-2]
24. Wu B, Zhang F, Yu M, Zhao P, Ji W, Zhang H, Han J, Niu R. Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells. Cell Prolif 2012; 45: 189-198 [PMID: 22452352 DOI: 10.1111/j.1365-2184.2012. 00820.x]
25. Gould KL, Woodgett JR, Isacke CM, Hunter T. The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol Cell Biol 1986; 6: 2738-2744 [PMID: 2946940]
26. Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, Tsirka SE. Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci 2011; 31: 14346-14360 [PMID: 21976520 DOI: 10.1523/JNEURO-SCI.3299-11.2011]
27. Wang CY, Chen CL, Tseng YL, Fang YT, Lin YS, Su WC, Chen CC, Chang KC, Wang YC, Lin CF. Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. J Biol Chem 2012; 287: 32512-32524 [PMID: 22859294]
28. Cha YH, Kim NH, Park C, Lee I, Kim HS, Yook JI. MiR-NA-34 intrinsically links p53 tumor suppressor and Wnt signaling. Cell Cycle 2012; 11: 1273-1281 [PMID: 22421157 DOI: 10.4161/cc.19618]
29. Grieve AG, Moss SE, Hayes MJ. Annexin A2 at the interface of actin and membrane dynamics: a focus on its roles in endocytosis and cell polarization. Int J Cell Biol 2012; 2012: 852430 [PMID: 22505935]
30. Zhou S, Yi T, Liu R, Bian C, Qi X, He X, Wang K, Li J, Zhao X, Huang C, Wei Y. Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of en-dometrial cells in human adenomyosis. Mol Cell Proteomics 2012; 11: M112.017988 [PMID: 22493182]
31. Sharma MC, Sharma M. The role of annexin II in angiogen-esis and tumor progression: a potential therapeutic target. Curr Pharm Des 2007; 13: 3568-3575 [PMID: 18220793 DOI: 10.2174/138161207782794167]
32. Zheng L, Jaffee EM. Annexin A2 is a new antigenic target for pancreatic cancer immunotherapy. Oncoimmunology 2012; 1: 112-114 [PMID: 22720228 DOI: 10.4161/onci.1.1.18017]
33. Huang Y, Jin Y, Yan CH, Yu Y, Bai J, Chen F, Zhao YZ, Fu SB. Involvement of Annexin A2 in p53 induced apoptosis in lung cancer. Mol Cell Biochem 2008; 309: 117-123 [PMID: 18008140 DOI: 10.1007/s11010-007-9649-5]
34. Leffer J, Herbert AP, Norström E, Schmidt CQ, Barlow PN, Blom AM, Martin M. Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells. J Biol Chem 2010; 285: 3766-3776 [PMID: 19951950 DOI: 10.1074/ jbc.M109.045427]
35. Zhang HJ, Yao DF, Yao M, Huang H, Wu W, Yan MJ, Yan XD, Chen J. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma. World J Gastroen-terol 2012; 18: 5897-5904 [PMID: 23139605 DOI: 10.3748/wjg. v18.i41.5897]